SOLICITATION NOTICE
R -- Consulting and Technical Facilitation Services for the NCI Workshop on the Feasibility of a Physical Activity, Weight Control Trial to Prevent Breast Cancer
- Notice Date
- 6/28/2006
- Notice Type
- Solicitation Notice
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
- ZIP Code
- 20852
- Solicitation Number
- Reference-Number-NCI-60094-NV
- Response Due
- 7/12/2006
- Archive Date
- 7/27/2006
- Description
- In accordance with simplified acquisition procedures The National Cancer Institute (NCI), Division of Cancer Control and Population Sciences (DCCPS), Applied Research Program (ARP) proposes to acquire, on a sole source basis, the continued consulting and facilitation services of Dr. Marianne H. Alciati Ph.D. of Management Solutions for Health, Inc., 1600 Waters Edge Lane, Reston, VA 20190. The ARP is leading an NCI effort to explore the feasibility of a national randomized controlled trial of the role of weight control through physical activity and/or reductions in caloric intake on breast cancer risk. A two-day workshop was held on March 15 and 16, 2006 and was co-sponsored by the Division of Cancer Prevention, the Division of Cancer Epidemiology and Genetics, the Division of Cancer Treatment and Diagnosis, the Center for Cancer Research, and the Office of Women?s Health. The purpose of this workshop was to address the issue of whether evidence is sufficient to justify a randomized, controlled trial on the efficacy of a physical activity, weight control intervention for prevention of either second occurrence of breast cancer in survivors or primary occurrence in high-risk women. Workshop proceedings focused on presentation of evidence from existing studies as well as study design and implementation lessons. This workshop provided an initial basis for assessing trial feasibility and potentially core trial characteristics. The outcome of the workshop is to be a summary document that contains the input and feedback provided during the meeting as well as input from participants afterwards on the issues related to a trial in this area. Due to the dense agenda and need for the participants to thoroughly consider the trial elements proposed at the meeting, collecting and assembling feedback from participants after the workshop is essential to formulating a trial design. Due to the complexity of the scientific question at hand, there were four separate working groups established to address the main issues in discussing the feasibility of a randomized control trial. These were identified as the Interventions Working Group, the trans-NIH Working Group, the Population and Questions Working Group, and the Mechanisms of Action Working Group. These groups have been identified and the working group members have been established. The working groups have been meeting through bi-weekly conference calls to discuss issue frameworks that have been developed. Working group members have also been participating in on-line discussions via email or through message boards that have been developed for specific topics. Management Solutions for Health, Inc shall: 1) Manage and facilitate the progress of the four already established working groups in their development of a final report. This will include: a) continued identification of follow-up issues for the working group to address; b) organize submission and refinement of draft working group reports at each round of revision; c) coordinate and schedule any necessary conference calls for the working groups including development of the call agenda, related materials (frameworks, draft reports, etc.) and follow-up communication; and d) compile references and track citations for 3 of the working groups (Populations and Questions Working Group, Mechanisms of Action Working Group, and the Interventions Working Group); 2) Coordinate the compilation of the final working group reports into one final report for all working groups. This will include: a) identify strategies for this consolidation across working groups; b) work with the working group co-chairs and NCI contacts to compile the reports into one document and providing editorial, review, and scientific expertise to the revisions of this document? c) facilitate any conference calls that are needed for this stage of the project; d) compile references across all the working groups for the final report; and e) identify strategies for presenting final decisions regarding trial design and assist in supporting the rationale for these decisions. Dr. Alciati worked as the facilitator for the establishment of the working groups after the March workshop and coordinated the first several rounds of reviews of the working group frameworks under Purchase Order # 263-MQ-606003. She is extremely knowledgeable of and familiar with the composition of the working groups, the process for the conference calls, material development by the working groups, and the remaining scientific questions that need to be resolved in the development of the final working group reports. Dr. Alciati?s work for the first part of the project was crucial in the management of the initial collection and synthesis of scientific input and evidence from over thirty experts in the field of cancer prevention. She efficiently facilitated the development of draft working group reports and is uniquely familiar with the remaining scientific issues that the working groups need to address to develop the final working group reports. This is not a solicitation for competitive quotations. However, if any interested party believes it can meet the entire above requirement, they may submit a statement of capabilities. All information furnished shall be in writing and must contain sufficient detail to allow the NCI researcher to determine if it can meet the requirements of this synopsis. An original and one copy of the capability statements must be received in the Contracting Office by 1PM EDT (local Washington, D.C. time) on July 12, 2006. Faxed and emailed capability statements are NOT authorized. All questions must be in writing and may be emailed to Debbie Moore at dm170b@nih.gov or faxed (301) 402-4513. It is the vendor?s responsibility to call (301) 402-4509 and verify that questions were received. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award from the NCI contractors must be registered in the Online Representations and Certifications Applications (ORCA). Please refer to http://orca.bpn.gov in order to register. In addition, contractors must be registered in the Central Contractor Registration (CCR) www.ccr.gov. No collect calls will be accepted. NAICS: 541990; Size Standard is 6 million.
- Record
- SN01079111-W 20060630/060628220355 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |